A key driving force in the market for wound management is the reduction of costs associated with managing chronic wounds. Central to this is clinical challenge of dealing with pressure ulcers. Below is an excerpt on pressure ulcers from the MedMarket Diligence report #S247, "Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets [...]
The market for tissue engineering and cell therapy products is set to grow to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
(See PRLog press release at link.) As well established as the practices are for the management of types 1 and 2 diabetes, a raft of new technologies, from modest to radical, are steadily entering clinical practice and the industry, according to a new report from MedMarket Diligence. FOR IMMEDIATE RELEASE PRLog (Press Release) – Aug [...]
Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies. By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]
This was the first large-scale study to show definitively the benefit of making efforts to keep blood glucose levels within tight limits. The results have had a significant effect on the directions of new diabetes management research. The Diabetes Control and Complications Trial (DCCT) was a 10-year study involving 1,441 people with insulin-dependent diabetes throughout [...]
Unlike type 1 diabetes, the initial management of the type 2 form of the disease is not dependent on insulin. Due to the different pathology of the type 2 diabetes, the management of this condition revolves around a strict regimen of exercise and diet (non-pharmacological means) and agents that aid insulin sensitivity (pharmacological methods). Another [...]
Historically, closure of surgical incisions has been achieved through an ever-evolving portfolio of suture, staple and tape products. In the early 1990s, physicians involved in sports medicine were the first non-military practitioners to adopt cyanoacrylate glues to achieve immediate closure of small cuts and lacerations, and an awareness of this opportunity developed in large multinational [...]
The subject of "tissue engineering and cell therapy" is, by some accounts, an artificial amalgam of the two separate subjects, particularly since cell therapy per se, as a result of its inextricable link to embryonic stem cells and abortion, seems to demand (at least by some) a wholly separate consideration. From a scientific basis, of [...]
Below is a listing (condensed from report #A145) of the specific primary applications indicated by manufacturers for the use of radiofrequency (RF) ablation embodied in their devices. As is apparent, RF ablation has penetrated the breadth of medical specialties due to its long history, its facile integration in the practices of a wide range of [...]
Contact:
